PXMB.F Stock Overview
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 6/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Paxman AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr2.80 |
| 52 Week High | kr3.01 |
| 52 Week Low | kr2.80 |
| Beta | 0.72 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -58.15% |
Recent News & Updates
Recent updates
Shareholder Returns
| PXMB.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.4% | 1.2% |
| 1Y | n/a | -0.7% | 24.7% |
Return vs Industry: Insufficient data to determine how PXMB.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how PXMB.F performed against the US Market.
Price Volatility
| PXMB.F volatility | |
|---|---|
| PXMB.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PXMB.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PXMB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 91 | Richard Paxman | paxmanscalpcooling.com |
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various clinics and treatment centers, and hospitals. The company has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device.
Paxman AB (publ) Fundamentals Summary
| PXMB.F fundamental statistics | |
|---|---|
| Market cap | US$62.36m |
| Earnings (TTM) | US$794.81k |
| Revenue (TTM) | US$21.28m |
78.5x
P/E Ratio2.9x
P/S RatioIs PXMB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PXMB.F income statement (TTM) | |
|---|---|
| Revenue | kr220.61m |
| Cost of Revenue | kr74.19m |
| Gross Profit | kr146.42m |
| Other Expenses | kr138.18m |
| Earnings | kr8.24m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 0.43 |
| Gross Margin | 66.37% |
| Net Profit Margin | 3.73% |
| Debt/Equity Ratio | 11.1% |
How did PXMB.F perform over the long term?
See historical performance and comparison